Revelation Biosciences, Inc. (REVBW) stock

REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $16.05MP/E –Yield –

Revelation Biosciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Revelation Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.